发明名称 PHOTOACTIVATION OF ENDOGENOUS PORPHYRINS FOR TREATMENT OF PSORIASIS
摘要 In one aspect, the invention provides a diagnostic method for identifying psoriatic plaques in which Porphyrins, particularly protoporphyrin IX, are elevated as compared to normal skin and skin of patients with other dermatological diseases, including other forms of psoriatic plaque. Psoriatic plaques with elevated porphyrin levels may be detected by fluorescence and spectral analysis. Endogenous porphyrins in psoriatic plaques may be activated with visible light to treat psoriatic plaques having elevated porphyrin concentrations. Skin conditions may be optimized to increase the endogenous concentration of porphyrins in psoriatic plaques. A topical formulation may be applied to psoriatic plaques to optimize skin conditions such as pH, iron concentration, temperature, hydration, calcium concentration, oxygenation, electrical conductivity and estrogen concentration to increase the concentration of endogenous porphyrins.
申请公布号 CA2238601(A1) 申请公布日期 1998.11.27
申请号 CA19982238601 申请日期 1998.05.25
申请人 THE UNIVERSITY OF BRITISH COLUMBIA 发明人 MCLEAN, DAVID I.;MACAULAY, CALUM;BISSONNETTE, ROBERT;ZENG, HAISHAN;LUI, HARVEY
分类号 A61K41/00;(IPC1-7):A61B5/00;A61K49/00;A61N5/06 主分类号 A61K41/00
代理机构 代理人
主权项
地址